Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...

Chromatography industry faces AI adoption challenges, workforce issues, and budget constraints, with biopharmaceutical sectors showing career growth. Peptide science is revolutionized by GLP-1 drugs, ...

The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients ...

The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.